iBionext
Sylvie Murgo is an accomplished IP Director with extensive experience in various biotechnology and pharmaceutical companies. Since 2006, Sylvie has held IP director positions at Transgene and Fovea Pharmaceuticals, subsequently serving in similar roles at GenSight Biologics, TISSIUM, BrainEver, and iBionext from 2013 to the present. Additional responsibilities include directorships at Chronolife and Tilak Healthcare until 2024, and Pixium Vision S.A. until 2024, as well as PROPHESEE until 2021. Sylvie holds a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from Strasbourg University, complemented by further education at CEIPI.
This person is not in any teams
This person is not in any offices